Article Information
History
- March 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1First Affiliated Hospital of Guangdong Pharmaceutical University, No.19 Nonglinxia Road, Guangzhou, 510080, China
- 2Guangdong metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases, No.280 Wai Huan Dong Road, Guangzhou 510006, China
- 3School of public health, Guangdong Pharmaceutical University, No.280 Outer Ring Road East, Guangzhou, 510006, China
- *Correspondence to: Prof Jiao Guo, Guangdong metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong TCM Key Laboratory for Metabolic Diseases, No.280 Wai Huan Dong Road, Guangzhou 510006, China. gyguoyz{at}163.com Tel: +8602039352818
Posted March 30, 2020.
Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis
